Compare Eli Lilly And Co (LLY) vs Petróleo Brasileiro SA (PBR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Petróleo Brasileiro SA — how do they compare? Eli Lilly And Co trades at $1,174.1 (market cap $1.02T), while Petróleo Brasileiro SA trades at $18.51 (market cap $108.78B). The key difference: Eli Lilly And Co is far larger — about 9.4× Petróleo Brasileiro SA's market cap, and Petróleo Brasileiro SA pays the higher dividend (9.81%). Which is the better fit depends on your goals.
| LLY | PBR | |
|---|---|---|
Market Cap | $1.02T | $108.78B |
Sector | Health | Technology |
52-Week High | $1.24K | $22.03 |
52-Week Low | $625.65 | $11.54 |
Enterprise Value | $1.06T | $171.32B |
Dividend Yield | 0.6% | 9.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Petróleo Brasileiro SA
Petróleo Brasileiro S.A., commonly known as Petrobras, is a state-controlled Brazilian multinational corporation in the oil and gas industry. The company is one of the world's largest producers of oil and gas, primarily operating in exploration, production, refining, and power generation. Petrobras is particularly known for its deep-sea and ultra-deep-sea exploration and production activities in the vast pre-salt offshore reserves, which are a major component of Brazil's economy.
Read more on PBR →
